A randomized, open-label, multiple doses, crossover study to evaluate a pharmacokinetic drug interaction and safety of Candesartan free combination of Candesartan and Amlodipine and Candesartan monotherapy in healthy male volunteers

Trial Profile

A randomized, open-label, multiple doses, crossover study to evaluate a pharmacokinetic drug interaction and safety of Candesartan free combination of Candesartan and Amlodipine and Candesartan monotherapy in healthy male volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

At a glance

  • Drugs Candesartan cilexetil (Primary) ; Amlodipine
  • Indications Cardiovascular disorders; Heart failure; Hypertension
  • Focus Pharmacokinetics
  • Acronyms CKD-330(C)
  • Sponsors Chong Kun Dang
  • Most Recent Events

    • 02 Sep 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
    • 09 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top